Pharma & Biopharma

We spoke with the minds behind this year’s scientific program – Michael Laemmerhofer and Oliver J. Schmitz – to find out how HPLC is shaping up

With many biologics patents soon to expire, can multimodal chromatography meet the growing demand for efficient downstream biosimilar production?

A single VUV system could replace a number of separate analytical techniques employed during API design and pharma manufacturing

How advances in next-generation sequencing are expanding the horizons of pharmacogenomic testing

The Application Book 2022 summarizes recent application notes across a range of exciting topics

Geneticist Eric Chow describes how genomic surveillance can identify emerging SARS-CoV-2 variants of concern

How KNAUERs new pump and liquid handler help bridge the gap between classic HPLC systems and the demand for fast, reproducible high-resolution methods

How can new LC-MS system help biopharma manufacturers?

Sagi Nahum and Dana Fuchs Telem from Orgenesis talk us through the central challenges – and solutions – in the analysis of cell and gene therapies

Geoff Winkett discusses developments in molecular spectroscopy and the growth of the biopharma market